Zobrazeno 1 - 10
of 20
pro vyhledávání: '"E R Broun"'
Autor:
LK Kunkel, Constance Danielson, Robert Hromas, C. M. Traycoff, K Cornetta, Mark P. Hanna, B Mills, Edward F. Srour, N Wyman, V Gharpure, Rafat Abonour, F. Oldham, René Gonin, E. R. Broun
Publikováno v:
Bone Marrow Transplantation. 21:65-71
Bone marrow cells expressing the surface antigen CD34 comprise approximately 1% of harvested marrow and are highly enriched for marrow progenitor cells, including the cells believed to be responsible for long-term engraftment following bone marrow tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e254cf3e7f4d35cc99b1c10a6c7bba
https://doi.org/10.1038/sj.bmt.1701048
https://doi.org/10.1038/sj.bmt.1701048
Autor:
George W. Sledge, Lawrence H. Einhorn, D Loesch, R Sridhara, Robert Hromas, E R Broun, P H Kneebone, Mark Hanna, K Cornetta
Publikováno v:
Journal of Clinical Oncology. 13:2050-2055
PURPOSE To investigate the tolerability and impact on progression-free and overall survival of two consecutive cycles of high-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) in patients with previously untreated metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2801a68cd97b7f15cde396290d698ee4
https://doi.org/10.1200/jco.1995.13.8.2050
https://doi.org/10.1200/jco.1995.13.8.2050
Autor:
E. R. Broun, W F Anderson, Kenneth Cornetta, R A Morgan, Robert Hromas, Edward F. Srour, G Tricot, Robert S. Hoffman, R C Moen
Publikováno v:
Human Gene Therapy. 3:305-318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c51487bc86606c63da74c0840510b00
https://doi.org/10.1089/hum.1992.3.3-305
https://doi.org/10.1089/hum.1992.3.3-305
Publikováno v:
Cancer Genetics and Cytogenetics. 46:125-128
A patient with refractory anemia with excess blasts (RAEB) and pancytopenia is reported. He was red blood cell (RBC)-transfusion dependent. Karyotype analysis showed a complex cytogenetic abnormality consisting of loss of chromosome 7 and trisomy 8.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d763db37e8bbf75860f1e727c8a6d6b1
https://doi.org/10.1016/0165-4608(90)90018-6
https://doi.org/10.1016/0165-4608(90)90018-6
Publikováno v:
American Journal of Clinical Oncology. 18:164-166
Twenty-two patients with recurrent ovarian cancer were entered into a Phase II trial of edatrexate at a dose of 80 mg/m 2 i.v. weekly for five consecutive weeks. One patient received an inadequate trial, and six did not complete one cycle due to adve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc42962f618632feed1ea7dd572b0f0
https://doi.org/10.1097/00000421-199504000-00015
https://doi.org/10.1097/00000421-199504000-00015
Publikováno v:
Cancer. 68:1513-1515
The authors reported their experience with the use of high-dose chemotherapy and autologous bone marrow rescue (ABMR) as salvage therapy in the treatment of patients with recurrent and refractory primary nonseminomatous mediastinal germ cell tumors (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e056359109ac6a950026458100497fe6
https://doi.org/10.1002/1097-0142(19911001)68:7<1513::aid-cncr2820680708>3.0.co
https://doi.org/10.1002/1097-0142(19911001)68:7<1513::aid-cncr2820680708>3.0.co
Publikováno v:
JAMA: The Journal of the American Medical Association. 264:1441-1443
Two patients with sideroblastic anemia secondary to zinc-induced copper deficiency absorbed excess zinc secondary to oral ingestion. The source of excess zinc was a zinc supplement in one case; in the other, ingested coins. In each case, the siderobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c60231aa8af2b1e0011ffd2374732b
https://doi.org/10.1001/jama.264.11.1441
https://doi.org/10.1001/jama.264.11.1441
Autor:
C H, Moskowitz, P, Stiff, M S, Gordon, I, McNiece, A D, Ho, J J, Costa, E R, Broun, R A, Bayer, M, Wyres, J, Hill, K, Jelaca-Maxwell, C R, Nichols, S L, Brown, S D, Nimer, J, Gabrilove
Publikováno v:
Blood. 89(9)
To examine the safety and efficacy of recombinant-methionyl human stem cell factor (r-metHuSCF), 38 patients with intermediate-grade or immunoblastic high-grade non-Hodgkin's lymphoma who were eligible for autologous transplantation were randomized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::609497d1c2bc156b6458195abd3b7cb5
https://pubmed.ncbi.nlm.nih.gov/9129016
https://pubmed.ncbi.nlm.nih.gov/9129016
Publikováno v:
Cancer. 79(8)
The purpose of this study was to evaluate the use of two cycles of high dose chemotherapy with autologous bone marrow transplantation (ABMT) in the treatment of patients having a first relapse of testicular germ cell cancer.Twenty-five patients whose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64bbc20ca9121cef1c71aa9f1c7bede5
https://pubmed.ncbi.nlm.nih.gov/9118046
https://pubmed.ncbi.nlm.nih.gov/9118046
Autor:
E R, Broun, C R, Nichols, M, Turns, S D, Williams, P J, Loehrer, B J, Roth, H M, Lazarus, L H, Einhorn
Publikováno v:
Cancer. 73(6)
Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous bone marrow rescue (ABMR) has shown curative potential in patients with relapsed and refrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf99b90b19304272c58b45fb0ab76c27
https://pubmed.ncbi.nlm.nih.gov/7512438
https://pubmed.ncbi.nlm.nih.gov/7512438